To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RNF34TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
521 supporting clones for gene RNF34 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR601814 B cells (Ramos cell line) Cot 25-normalized .a 1 to 1681 5 to 1685 exact tiling clone,   1685/1685
(100 %)
0 diff
(100 %id)
BX342871   .a 1 to 760 5 to 764   fully sequenced,   764/764
(100 %)
1 diff
(99.9 %id)
BY995383   .a 71 to 747 22 to 698       677/698
(96 %)
6 diff
(99.2 %id)
CU455244 epidermis .a 88 to 725 652 to 15     Submitted on the opposite strand 638/653
(97 %)
0 diff
(100 %id)
CN391509 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 139 to 802 1 to 664       664/664
(100 %)
0 diff
(100 %id)
DA606056   .a 152 to 686 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
CN391508 embryonic stem cells, cell lines H1, H7, andH9 .a 188 to 307 1 to 120       120/120
(100 %)
1 diff
(99.2 %id)
BI086970 cervix .a 194 to 755 1 to 568       568/1044
(54 %)
10 diff
(99.1 %id)
BU178575 eye, retinoblastoma .a 216 to 1074 12 to 874       863/877
(98 %)
13 diff
(98.6 %id)
BF771162 epid_tumor .a 230 to 599 378 to 3     Submitted on the opposite strand 376/378
(99 %)
1 diff
(99.8 %id)
BI049480 placenta_normal .a 245 to 661 416 to 1       416/416
(100 %)
2 diff
(99.6 %id)
CD521253 pooled .a 259 to 778 1 to 523       523/819
(63 %)
11 diff
(98.7 %id)
AA366087 Pancreas .a 279 to 622 1 to 345       345/349
(98 %)
2 diff
(99.5 %id)
CV813820 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 284 to 998 34 to 748       715/896
(79 %)
8 diff
(99.2 %id)
DA611765   .a 293 to 876 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CV800188 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 309 to 987 1 to 675       675/830
(81 %)
5 diff
(99.4 %id)
CX761305 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 312 to 1028 1 to 711     Submitted on the opposite strand 713/831
(85 %)
18 diff
(97.9 %id)
BG339314 leiomyosarcoma cell line, uterus .a 339 to 993 1 to 647       647/909
(71 %)
11 diff
(98.8 %id)
BP326863 prostata .a 344 to 791 1 to 448       448/552
(81 %)
3 diff
(99.5 %id)
BF996525 placenta_normal .a 356 to 745 395 to 3       393/395
(99 %)
5 diff
(98.8 %id)
BM127506 Islets of Langerhans, Pancreas .a 389 to 926 1 to 538       538/538
(100 %)
0 diff
(100 %id)
AW402965 lymph .a 398 to 778 7 to 387       381/387
(98 %)
10 diff
(97.5 %id)
BP308876 brain .a 410 to 942 1 to 531       531/588
(90 %)
20 diff
(96.6 %id)
AW005173 anaplastic oligodendroglioma, brain .a 458 to 965 508 to 1       508/508
(100 %)
0 diff
(100 %id)
CK906126 Islets of Langerhans, Pancreas .a 458 to 726 1 to 269       269/269
(100 %)
0 diff
(100 %id)
BQ932331 leiomyosarcoma, uterus .a 463 to 993 1 to 532       532/1474
(36 %)
18 diff
(98.8 %id)
H23102 whole brain .a 482 to 911 1 to 437       437/438
(99 %)
18 diff
(95.9 %id)
CB269217 adipose .a 510 to 846 1 to 336       336/337
(99 %)
3 diff
(99.2 %id)
AA361315   .a 527 to 863 1 to 338       338/341
(99 %)
6 diff
(98.3 %id)
CF146107 CNCAP(3)T-225 cell line, Prostate .a 575 to 926 8 to 359       352/359
(98 %)
6 diff
(98.4 %id)
AI695899 pooled germ cell tumors .a 697 to 965 270 to 1       270/281
(96 %)
2 diff
(99.3 %id)
BI015726 lung_tumor .a 721 to 931 213 to 1       213/218
(97 %)
8 diff
(96.4 %id)
BX342870   .a 730 to 1661 946 to 17   fully sequenced,   930/946
(98 %)
0 diff
(100 %id)
FN173359 breast carcinoma .a 804 to 895 1 to 93       93/93
(100 %)
4 diff
(95.7 %id)
FN164371 breast carcinoma .a 806 to 874 1 to 69       69/69
(100 %)
3 diff
(95.7 %id)
BU618479 Cell Line, Chondrosarcoma .a 1138 to 1714 594 to 19   AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 576/576
(100 %)
3 diff
(99.5 %id)
AA779208 liver and spleen .a 1193 to 1714 523 to 1       523/523
(100 %)
5 diff
(99.1 %id)
BU619795 Cell Line, Chondrosarcoma .a 1219 to 1714 516 to 19   AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 498/500
(99 %)
2 diff
(99.6 %id)
AA406607 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1226 to 1714 488 to 1       488/488
(100 %)
2 diff
(99.6 %id)
AI088992 pooled .a 1235 to 1714 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AI288446 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1253 to 1714 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AI128092 uterus .a 1254 to 1718 470 to 6   tiling clone,   465/470
(98 %)
0 diff
(100 %id)
AI472214 pooled .a 1263 to 1714 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI741703 pooled .a 1269 to 1714 466 to 21   AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 446/446
(100 %)
1 diff
(99.8 %id)
AI589445 adenocarcinoma, Pancreas .a 1347 to 1715 368 to 1       368/368
(100 %)
2 diff
(99.5 %id)
AW366505 head_neck .a 1401 to 1557 1 to 157       157/157
(100 %)
1 diff
(99.4 %id)
AI364651 B-cell, chronic lymphotic leukemia .a 1401 to 1716 314 to 1       314/316
(99 %)
2 diff
(99.4 %id)
NM_194271.1   .b 1 to 2075 1 to 2075 exact RefSeq, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 2075/2075
(100 %)
0 diff
(100 %id)
DA077266 cerebellum .b 18 to 584 2 to 570   tiling clone, capped   569/569
(100 %)
2 diff
(99.7 %id)
DA753245   .b 21 to 472 2 to 453   capped   452/452
(100 %)
0 diff
(100 %id)
DA827793 pericardium .b 21 to 576 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA887995   .b 21 to 585 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AL557811 T cells from T cell leukemia .b 24 to 1039 16 to 1014   tiling clone, fully sequenced,   999/1014
(98 %)
21 diff
(98.0 %id)
CX787376 human embryonic stem cells .b 24 to 794 1 to 771       771/771
(100 %)
0 diff
(100 %id)
BI560557 testis .b 28 to 810 1 to 781       781/811
(96 %)
9 diff
(98.9 %id)
BF673157 muscle (skeletal) .b 30 to 786 1 to 760       760/832
(91 %)
24 diff
(97.2 %id)
DC418305 trachea .b 31 to 585 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
TI_44349545   .b 32 to 810 95 to 871       777/901
(86 %)
12 diff
(98.7 %id)
CV317334 colon .b 35 to 241 1 to 211       210/221
(95 %)
24 diff
(89.2 %id)
TI_57182407   .b 39 to 859 32 to 862       829/862
(96 %)
28 diff
(96.8 %id)
BI771892 pooled lung and spleen .b 43 to 859 1 to 827       825/827
(99 %)
22 diff
(97.4 %id)
BG170891 hypernephroma, cell line, Kidney .b 44 to 805 1 to 763   AAA   763/921
(82 %)
45 diff
(95.2 %id)
BG419572 Kidney, renal cell adenocarcinoma .b 44 to 757 1 to 711       711/712
(99 %)
8 diff
(98.9 %id)
N46057 melanocyte .b 46 to 300 9 to 264       256/264
(96 %)
10 diff
(96.3 %id)
BP205434 coronary artery .b 49 to 628 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA269002 caudate nucleus .b 50 to 597 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA360613 subthalamic nucleus .b 50 to 608 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
CN274775 embryonic stem cells, DMSO-treated H9 cellline .b 59 to 224 1 to 166       166/166
(100 %)
1 diff
(99.4 %id)
CX786344 human embryonic stem cells .b 96 to 835 1 to 740       740/740
(100 %)
0 diff
(100 %id)
DR004620 placenta .b 161 to 846 10 to 694       685/694
(98 %)
16 diff
(97.7 %id)
AB084914   .b 178 to 1299 1 to 1122 exact tiling clone,   1122/1122
(100 %)
0 diff
(100 %id)
AL579774 T cells from T cell leukemia .b 1009 to 2028 1016 to 1   tiling clone, fully sequenced,   1016/1016
(100 %)
15 diff
(98.6 %id)
N36836 melanocyte .b 1622 to 2066 451 to 2   tiling clone,   450/451
(99 %)
0 diff
(100 %id)
AF306709 brain .c 1 to 2066 1 to 2065 exact tiling clone,   2065/2070
(99 %)
2 diff
(100.0 %id)
DB242808 stomach, tumor tissue .c 44 to 599 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA822031 pericardium .c 48 to 617 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
BP251151 hippocampus .c 50 to 631 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CD519510 White Matter .c 59 to 853 1 to 795       795/865
(91 %)
7 diff
(99.2 %id)
NM_025126.2   .c 59 to 2067 1 to 2009 exact RefSeq, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 2009/2009
(100 %)
0 diff
(100 %id)
CD687621 normal nasopharynx .c 61 to 574 25 to 538       514/538
(95 %)
6 diff
(98.9 %id)
BG899699 cartilage .c 62 to 387 83 to 409       327/341
(95 %)
10 diff
(97.1 %id)
TI_45213216   .c 64 to 814 121 to 872       752/878
(85 %)
17 diff
(98.1 %id)
DA078716 cerebellum .c 66 to 534 2 to 471   capped   470/470
(100 %)
1 diff
(99.8 %id)
AL710970 human skeletal muscle .c 68 to 548 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
FN065804 breast carcinoma .c 68 to 137 70 to 1     Submitted on the opposite strand 70/72
(97 %)
0 diff
(100 %id)
BF242169 bone marrow, from acute myelogenous leukemia .c 72 to 734 1 to 661       661/756
(87 %)
41 diff
(94.6 %id)
BG715244 brain, hypothalamus .c 72 to 714 1 to 647       647/649
(99 %)
11 diff
(98.4 %id)
BI598912 brain, hypothalamus .c 72 to 814 1 to 744       744/750
(99 %)
13 diff
(98.3 %id)
BJ991652 hepatoblastoma .c 73 to 561 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
DA181231 amygdala .c 76 to 653 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA737574   .c 77 to 898 2 to 825   capped   824/833
(98 %)
6 diff
(99.3 %id)
BM839804 myeloma .c 77 to 629 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BM846240 myeloma .c 77 to 773 1 to 697       697/697
(100 %)
2 diff
(99.8 %id)
BP372069 umbilical cord .c 77 to 631 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
AK025439   .c 78 to 2067 1 to 1990 Y183C N238D I333V tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 1990/1990
(100 %)
4 diff
(99.8 %id)
AK225285 Liver .c 78 to 1901 1 to 1824 Y183C N238D I333V     1824/1824
(100 %)
4 diff
(99.8 %id)
DA284159 corpus callosum .c 78 to 641 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA365908 subthalamic nucleus .c 78 to 631 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB497743.
matches multiple genes
hypothalamus .c 78 to 588 1 to 511     also hits gene KDM2B 511/511
(100 %)
1 diff
(99.9 %id)
DA549490   .c 78 to 635 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
BP237453 Liver .c 78 to 705 1 to 628       628/628
(100 %)
5 diff
(99.3 %id)
BP253033 Kidney .c 78 to 652 1 to 575       575/575
(100 %)
5 diff
(99.2 %id)
BP318508 pericardium .c 78 to 665 1 to 588       588/588
(100 %)
0 diff
(100 %id)
DB133588 thymus .c 78 to 635 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA005942   .c 79 to 640 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA062754 cerebellum .c 79 to 639 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA064400 cerebellum .c 79 to 654 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA098044 cerebellum .c 79 to 622 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA110501 cerebellum .c 79 to 652 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA140821 alzheimer cortex .c 79 to 697 2 to 620   capped   619/619
(100 %)
0 diff
(100 %id)
DA156777 amygdala .c 79 to 589 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DA160833 amygdala .c 79 to 650 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA218132 brain .c 79 to 618 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA268133 caudate nucleus .c 79 to 650 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA324945 hippocampus .c 79 to 635 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA324985 hippocampus .c 79 to 592 2 to 517   capped   516/516
(100 %)
2 diff
(99.7 %id)
DA371599 thalamus .c 79 to 637 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA385800 thalamus .c 79 to 675 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA489793 brain .c 79 to 631 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA490590 brain .c 79 to 635 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA515946 brain .c 79 to 630 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA527249 brain .c 79 to 665 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA549760   .c 79 to 640 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA634555 Kidney .c 79 to 635 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA759803   .c 79 to 618 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA865966 Prostate .c 79 to 635 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA903173   .c 79 to 644 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA910945   .c 79 to 635 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA918788 small intestine .c 79 to 648 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA918795 small intestine .c 79 to 646 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA919517 small intestine .c 79 to 657 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA927286 small intestine .c 79 to 652 2 to 577   capped   576/576
(100 %)
5 diff
(99.2 %id)
DB004185 breast, tumor tissue .c 79 to 627 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB005009 breast, tumor tissue .c 79 to 611 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DB025710 testis .c 79 to 631 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB027429 testis .c 79 to 664 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB028723 testis .c 79 to 676 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DB051245 testis .c 79 to 635 2 to 562   capped   561/561
(100 %)
5 diff
(99.2 %id)
DB064846 testis .c 79 to 615 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DB066933 testis .c 79 to 534 2 to 458   capped   457/457
(100 %)
1 diff
(99.8 %id)
DB066962 testis .c 79 to 641 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB134037 thymus .c 79 to 630 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB262950 uterus .c 79 to 681 2 to 606   capped   605/606
(99 %)
3 diff
(99.6 %id)
DA666034   .c 80 to 632 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BG532818 embryonal carcinoma, testis .c 81 to 805 1 to 761       701/868
(80 %)
56 diff
(93.6 %id)
DB461376.
matches multiple genes
testis .c 82 to 565 1 to 484     also hits gene KDM2B 484/485
(99 %)
1 diff
(99.8 %id)
DB463543.
matches multiple genes
hippocampus .c 82 to 504 1 to 423     also hits gene KDM2B 423/423
(100 %)
0 diff
(100 %id)
CV571360 cornea, eye .c 82 to 710 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BG390778 embryonal carcinoma, cell line, testis .c 83 to 809 1 to 733       733/739
(99 %)
7 diff
(99.1 %id)
CA866704 Pancreas, Purified pancreatic islet .c 83 to 718 1 to 636       636/636
(100 %)
5 diff
(99.3 %id)
CN391507 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 84 to 675 7 to 598       592/598
(98 %)
6 diff
(99.0 %id)
AL599591   .c 84 to 331 1 to 249       249/249
(100 %)
2 diff
(99.2 %id)
AL601632   .c 84 to 676 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BM193153 leukopheresis .c 87 to 537 1 to 451       451/451
(100 %)
8 diff
(98.3 %id)
DA059262 cerebellum .c 88 to 644 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BG497699 adenocarcinoma, Prostate .c 88 to 846 1 to 754       754/754
(100 %)
11 diff
(98.6 %id)
BG502058 embryonal carcinoma, testis .c 88 to 809 1 to 722       722/724
(99 %)
7 diff
(99.1 %id)
BG541101 lung .c 88 to 810 1 to 727       727/837
(86 %)
34 diff
(96.0 %id)
DA820824 pericardium .c 88 to 659 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DB451328.
matches multiple genes
testis .c 89 to 567 1 to 479     also hits gene KDM2B 479/479
(100 %)
6 diff
(98.8 %id)
DB451329.
matches multiple genes
testis .c 89 to 570 1 to 482     also hits gene KDM2B 482/482
(100 %)
0 diff
(100 %id)
DA589286 lung .c 89 to 673 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA164269 amygdala .c 90 to 561 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
DA175085 amygdala .c 90 to 642 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA304153 hippocampus .c 90 to 552 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
DA356008 subthalamic nucleus .c 90 to 650 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA419366 cord Blood .c 90 to 660 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
CD685273 normal nasopharynx .c 90 to 691 22 to 623       602/623
(96 %)
10 diff
(98.4 %id)
DA529005 brain .c 90 to 687 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
BQ921302 leiomyosarcoma, uterus .c 90 to 963 1 to 876       876/929
(94 %)
12 diff
(98.8 %id)
DA618469   .c 90 to 665 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA620604   .c 90 to 658 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA823336 pericardium .c 90 to 639 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA986327 synovial membrane tissue from rheumatioidarthritis .c 90 to 660 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DB246137 uterus, tumor tissue .c 90 to 630 2 to 545   capped   544/544
(100 %)
4 diff
(99.3 %id)
BG501726 embryonal carcinoma, testis .c 91 to 821 1 to 728       728/747
(97 %)
22 diff
(97.1 %id)
DA757398   .c 91 to 638 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
BP320485 placenta .c 91 to 688 1 to 598       598/598
(100 %)
4 diff
(99.4 %id)
BP351152   .c 91 to 673 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA041474 bladder .c 92 to 654 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DA155475 amygdala .c 92 to 653 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BX404946 B cells (Ramos cell line) .c 92 to 1023 1 to 929       929/929
(100 %)
11 diff
(98.9 %id)
DA579176   .c 92 to 612 2 to 524   capped   523/523
(100 %)
2 diff
(99.7 %id)
DA826597 pericardium .c 92 to 661 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA258459 caudate nucleus .c 94 to 650 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA369900 subthalamic nucleus .c 94 to 614 29 to 549   capped   521/548
(95 %)
6 diff
(99.0 %id)
BU181539 eye, retinoblastoma .c 94 to 956 1 to 874       874/876
(99 %)
14 diff
(98.5 %id)
BP275828 Kidney .c 94 to 674 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA324557 hippocampus .c 95 to 659 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA359477 subthalamic nucleus .c 95 to 642 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
CD697078 normal nasopharynx .c 95 to 397 1 to 305       305/305
(100 %)
8 diff
(97.4 %id)
DA478673   .c 95 to 648 2 to 556   capped   555/559
(99 %)
2 diff
(99.7 %id)
DA999064 breast, tumor tissue .c 95 to 582 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
DN989892 brain, whole brain .c 95 to 785 1 to 690       690/690
(100 %)
3 diff
(99.6 %id)
DB243397 stomach, tumor tissue .c 95 to 631 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
AA297673 brain .c 96 to 380 1 to 285       285/285
(100 %)
3 diff
(99.0 %id)
BX374656 Neuroblastoma Cot 10-normalized .c 96 to 984 1 to 890       890/890
(100 %)
6 diff
(99.4 %id)
DA472522   .c 96 to 651 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM550002 leukocyte .c 97 to 896 17 to 816       800/1044
(76 %)
16 diff
(98.5 %id)
TI_57235722   .c 97 to 848 26 to 779       754/779
(96 %)
7 diff
(99.2 %id)
TI_57176109   .c 97 to 861 60 to 827       701/904
(77 %)
20 diff
(97.8 %id)
TI_57242492   .c 97 to 843 63 to 802       740/802
(92 %)
12 diff
(98.6 %id)
ES313003 beard hair, skin .c 100 to 248 1 to 149       149/149
(100 %)
2 diff
(98.7 %id)
BI753327 brain .c 100 to 915 1 to 816       816/816
(100 %)
4 diff
(99.6 %id)
BI917816 brain .c 100 to 884 1 to 788       786/788
(99 %)
11 diff
(98.7 %id)
TI_57217961   .c 100 to 915 36 to 851       816/851
(95 %)
10 diff
(98.9 %id)
TI_57243937   .c 100 to 884 70 to 857       786/857
(91 %)
17 diff
(98.1 %id)
BI829192 brain, medulla .c 101 to 861 1 to 764       697/841
(82 %)
14 diff
(98.4 %id)
BI910434 leukocyte .c 101 to 848 1 to 750       750/750
(100 %)
2 diff
(99.8 %id)
BI917898 brain .c 101 to 843 1 to 736       736/736
(100 %)
8 diff
(99.0 %id)
CX751742 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 101 to 820 1 to 720     Submitted on the opposite strand 720/720
(100 %)
0 diff
(100 %id)
CR991933 T-Lymphocytes .c 101 to 924 1 to 826       826/826
(100 %)
5 diff
(99.4 %id)
Z44055 brain, total brain .c 102 to 431 1 to 330       330/330
(100 %)
0 diff
(100 %id)
CR616780 Placenta Cot 25-normalized .c 102 to 2051 1 to 1950 exact     1950/1950
(100 %)
0 diff
(100 %id)
AL551294 placenta, Placenta Cot 25-normalized .c 102 to 1100 1 to 1001       1001/1093
(91 %)
32 diff
(97.1 %id)
BU521675 leiomyosarcoma, uterus .c 103 to 938 1 to 837       837/896
(93 %)
19 diff
(97.9 %id)
CD697981 normal nasopharynx .c 104 to 572 31 to 499       469/499
(93 %)
9 diff
(98.2 %id)
BM450362 eye, retinoblastoma .c 104 to 816 13 to 734       722/1038
(69 %)
26 diff
(97.5 %id)
AA135318 colon, tumor .c 105 to 397 1 to 292       292/293
(99 %)
5 diff
(98.3 %id)
BM545707 ovary (pool of 3) .c 105 to 899 1 to 796       796/973
(81 %)
8 diff
(99.2 %id)
CX754033 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 106 to 873 1 to 755     Submitted on the opposite strand 755/761
(99 %)
15 diff
(98.1 %id)
DA176482 amygdala .c 108 to 616 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
DA534728 heart .c 108 to 649 10 to 551   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA627345 Kidney .c 108 to 652 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA699773   .c 108 to 618 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
DA821784 pericardium .c 108 to 678 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA907522   .c 108 to 661 2 to 556   capped   553/555
(99 %)
1 diff
(99.9 %id)
AA297470 endometrium .c 110 to 403 1 to 294       294/294
(100 %)
0 diff
(100 %id)
CN391510 embryonic stem cells, cell lines H1, H7, andH9 .c 110 to 673 13 to 576       564/576
(97 %)
6 diff
(99.0 %id)
BE538995 cervix .c 110 to 845 1 to 748       748/798
(93 %)
32 diff
(96.0 %id)
CF780672 Pooled Chondrosarcoma Tumor cells .c 111 to 889 1 to 770       770/934
(82 %)
21 diff
(97.8 %id)
TI_57234804   .c 111 to 898 24 to 813       790/827
(95 %)
15 diff
(98.2 %id)
BF131990 hypernephroma, Kidney .c 113 to 784 1 to 682       682/812
(83 %)
30 diff
(96.4 %id)
BI772644 pooled lung and spleen .c 113 to 865 28 to 781       754/781
(96 %)
8 diff
(99.0 %id)
TI_57178427   .c 113 to 865 28 to 781       754/781
(96 %)
8 diff
(99.0 %id)
AL555153 placenta .c 114 to 1021 1 to 908       908/908
(100 %)
2 diff
(99.8 %id)
TI_57182972   .c 114 to 855 64 to 805       742/805
(92 %)
6 diff
(99.3 %id)
BY796553 eye .c 115 to 723 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BI907754 leukocyte .c 117 to 898 1 to 784       784/798
(98 %)
9 diff
(98.9 %id)
BC007826 Kidney, renal cell adenocarcinoma .c 118 to 2063 1 to 1946 exact available from MGC, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 1946/1946
(100 %)
0 diff
(100 %id)
BI771113 pooled lung and spleen .c 118 to 855 1 to 738       738/738
(100 %)
0 diff
(100 %id)
CN391511 embryonic stem cells, DMSO-treated H9 cellline .c 120 to 765 1 to 646       646/646
(100 %)
0 diff
(100 %id)
CB120192 Liver .c 122 to 512 1 to 391       391/391
(100 %)
0 diff
(100 %id)
BE272496 Kidney, renal cell adenocarcinoma .c 137 to 676 1 to 539       539/540
(99 %)
2 diff
(99.7 %id)
BI521346 pooled pancreas and spleen .c 150 to 880 1 to 730       730/730
(100 %)
2 diff
(99.8 %id)
TI_1948123408   .c 172 to 867 126 to 822   fully sequenced,   697/822
(84 %)
2 diff
(99.8 %id)
TI_1948123585   .c 172 to 836 127 to 792   fully sequenced,   666/792
(84 %)
0 diff
(100 %id)
TI_1948123754   .c 172 to 867 126 to 821   fully sequenced,   696/821
(84 %)
1 diff
(99.9 %id)
TI_1948123919   .c 172 to 867 128 to 823   fully sequenced,   696/823
(84 %)
0 diff
(100 %id)
AY098934   .c 173 to 1288 1 to 1116       1116/1116
(100 %)
0 diff
(100 %id)
BT007283   .c 173 to 1289 1 to 1117       1117/1119
(99 %)
1 diff
(100.0 %id)
CR457342   .c 173 to 1287 1 to 1115       1115/1119
(99 %)
1 diff
(100.0 %id)
CV026995 mixed .c 173 to 759 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BF149416 skin .c 177 to 612 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
H25211 whole brain .c 177 to 571 22 to 418     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 397/420
(94 %)
18 diff
(95.8 %id)
AW161368 brain, frontal lobe .c 233 to 508 1 to 275       275/275
(100 %)
3 diff
(99.0 %id)
AA452343   .c 352 to 802 1 to 450       450/450
(100 %)
4 diff
(99.2 %id)
BM454887 leiomyosarcoma, uterus .c 514 to 1484 8 to 988       981/1083
(90 %)
25 diff
(97.7 %id)
R59956 whole brain .c 558 to 924 1 to 368     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 368/385
(95 %)
1 diff
(99.8 %id)
TI_151797020   .c 562 to 1105 156 to 702       547/750
(72 %)
26 diff
(96.6 %id)
AA504590 germinal center B cell .c 588 to 979 1 to 392     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 392/392
(100 %)
1 diff
(99.8 %id)
CR983462 T-Lymphocytes .c 623 to 1475 1 to 855       855/855
(100 %)
2 diff
(99.8 %id)
BG117984 adenocarcinoma, cell line, Liver .c 681 to 1420 1 to 732       732/944
(77 %)
22 diff
(97.7 %id)
BE546400 cervical carcinoma cell line, cervix .c 750 to 1369 1 to 628       628/662
(94 %)
46 diff
(93.1 %id)
CF141274 CNCAP(3)T-225 cell line, Prostate .c 776 to 1299 1 to 524       524/524
(100 %)
7 diff
(98.7 %id)
CX762790 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 776 to 1459 1 to 684       684/684
(100 %)
0 diff
(100 %id)
CX165254 human embryonic stem cells differentiated toan early endodermal cell type .c 777 to 1553 1 to 777       777/777
(100 %)
1 diff
(99.9 %id)
TI_154171936   .c 783 to 1421 87 to 730       644/1070
(60 %)
19 diff
(98.3 %id)
R88644 brain .c 796 to 1032 1 to 235       235/237
(99 %)
7 diff
(97.1 %id)
TI_1948123586   .c 804 to 1290 615 to 129   fully sequenced,   487/615
(79 %)
0 diff
(100 %id)
CF597072 ovary .c 806 to 1499 1 to 700       700/782
(89 %)
10 diff
(98.8 %id)
TI_1948123409   .c 837 to 1290 580 to 127   fully sequenced,   454/580
(78 %)
0 diff
(100 %id)
TI_1948123755   .c 837 to 1290 581 to 128   fully sequenced,   454/581
(78 %)
0 diff
(100 %id)
TI_1948123920   .c 837 to 1290 582 to 129   fully sequenced,   454/582
(78 %)
0 diff
(100 %id)
CF140514 CNCAP(3)T-225 cell line, Prostate .c 848 to 1295 1 to 449       449/449
(100 %)
3 diff
(99.4 %id)
CF140586 CNCAP(3)T-225 cell line, Prostate .c 848 to 1296 1 to 451       451/451
(100 %)
4 diff
(99.2 %id)
CB132688 Liver .c 849 to 1493 1 to 645       645/645
(100 %)
0 diff
(100 %id)
CB147636 Liver .c 849 to 1505 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
TI_154171020   .c 854 to 1406 90 to 649       560/1000
(56 %)
21 diff
(97.9 %id)
TI_154171101   .c 854 to 1535 92 to 776       685/1104
(62 %)
22 diff
(98.1 %id)
BM709990 eye, optic nerve .c 863 to 1343 1 to 481     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
AA448572   .c 880 to 1082 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
BE742308 adenocarcinoma cell line, ovary .c 885 to 1580 1 to 696       696/920
(75 %)
9 diff
(99.1 %id)
AA135205 colon, tumor .c 898 to 1324 428 to 1       428/429
(99 %)
3 diff
(99.4 %id)
BM917793 blood, natural killer cells, cell line .c 899 to 1749 1 to 853       853/1056
(80 %)
27 diff
(97.5 %id)
BE897446 melanotic melanoma, skin .c 933 to 1687 1 to 752       752/769
(97 %)
14 diff
(98.2 %id)
CR592405 HeLa cells Cot 25-normalized .c 1031 to 2063 1 to 1033       1033/1033
(100 %)
0 diff
(100 %id)
BX363156   .c 1031 to 1992 1 to 958       958/1012
(94 %)
8 diff
(99.3 %id)
BX447516 B cells (Ramos cell line) .c 1038 to 1984 958 to 11       948/958
(98 %)
2 diff
(99.8 %id)
DR423671 eye, Pterygium .c 1054 to 1855 1 to 801       801/801
(100 %)
2 diff
(99.8 %id)
H80672 liver and spleen .c 1057 to 1417 1 to 366       366/374
(97 %)
6 diff
(98.4 %id)
N84351   .c 1099 to 1351 1 to 256       256/262
(97 %)
16 diff
(93.9 %id)
BG483425 lung .c 1100 to 1638 1 to 549       549/621
(88 %)
28 diff
(95.5 %id)
AL574919 placenta, Placenta Cot 25-normalized .c 1101 to 2051 949 to 1       949/1137
(83 %)
10 diff
(99.2 %id)
CR747752 melanotic melanoma, skin .c 1104 to 1596 11 to 503       493/503
(98 %)
6 diff
(98.9 %id)
BQ440898 melanotic melanoma, skin .c 1106 to 1976 1 to 882       882/884
(99 %)
15 diff
(98.4 %id)
AL577729 placenta .c 1111 to 2036 925 to 1       925/925
(100 %)
6 diff
(99.4 %id)
BE895367 melanotic melanoma, skin .c 1111 to 1813 1 to 702       702/934
(75 %)
13 diff
(98.7 %id)
BM691615 eye, RPE and Choroid .c 1129 to 1609 7 to 487       481/487
(98 %)
6 diff
(98.8 %id)
EL948367 eyeball .c 1133 to 1733 12 to 612       601/612
(98 %)
8 diff
(98.7 %id)
CA777047 Pancreas, Purified pancreatic islet .c 1133 to 1604 1 to 472   fully sequenced,   472/472
(100 %)
0 diff
(100 %id)
CD559310 pooled .c 1144 to 1873 1 to 737       737/742
(99 %)
13 diff
(98.3 %id)
BX372547 Neuroblastoma Cot 10-normalized .c 1175 to 2043 893 to 11       883/915
(96 %)
0 diff
(100 %id)
TI_154055118   .c 1177 to 2066 967 to 89   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 879/989
(88 %)
17 diff
(98.3 %id)
FN071173 breast carcinoma .c 1190 to 1247 1 to 58       58/63
(92 %)
1 diff
(98.5 %id)
TI_149299065   .c 1194 to 2057 941 to 92   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 850/933
(91 %)
15 diff
(98.4 %id)
TI_151711002   .c 1399 to 2065 790 to 124       667/790
(84 %)
0 diff
(100 %id)
CA866963 Pancreas, Purified pancreatic islet .c 1449 to 2062 614 to 1       614/614
(100 %)
0 diff
(100 %id)
BM671135 eye, optic nerve .c 1464 to 2063 618 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 600/600
(100 %)
0 diff
(100 %id)
AW161824 brain, frontal lobe .c 1474 to 2061 592 to 5       588/592
(99 %)
0 diff
(100 %id)
DB370188   .c 1509 to 2063 556 to 1       556/558
(99 %)
2 diff
(99.7 %id)
BJ991653 hepatoblastoma .c 1521 to 2043 523 to 1       523/523
(100 %)
0 diff
(100 %id)
CA776768 Pancreas, Purified pancreatic islet .c 1574 to 2063 490 to 1   fully sequenced,   490/490
(100 %)
0 diff
(100 %id)
AA449719   .c 1592 to 2061 473 to 5       469/473
(99 %)
0 diff
(100 %id)
H24392 whole brain .c 1654 to 2064 446 to 26   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 421/421
(100 %)
17 diff
(96.0 %id)
R59957 whole brain .c 1658 to 2066 436 to 13   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 424/428
(99 %)
16 diff
(96.3 %id)
H80635 liver and spleen .c 1668 to 2056 397 to 6       392/398
(98 %)
0 diff
(100 %id)
AA452121   .c 1684 to 2057 374 to 1       374/374
(100 %)
0 diff
(100 %id)
AA504507 germinal center B cell .c 1701 to 2064 378 to 15   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 364/364
(100 %)
1 diff
(99.8 %id)
R88580 brain .c 1848 to 2061 221 to 8       214/221
(96 %)
0 diff
(100 %id)
BE542155 cervix .c 2647 to 2734 658 to 743   tiling clone,   700/792
(88 %)
61 diff
(92.3 %id)
BX404978 B cells (Ramos cell line) .d 1 to 909 1 to 909   tiling clone,   909/912
(99 %)
6 diff
(99.4 %id)
BX404977 B cells (Ramos cell line) .d 1302 to 2253 952 to 1   tiling clone,   952/956
(99 %)
7 diff
(99.3 %id)
AK304366 trachea .e 1 to 1612 1 to 1612 exact tiling clone,   1612/1612
(100 %)
2 diff
(99.9 %id)
CX786629 human embryonic stem cells .e 631 to 1486 1 to 855   tiling clone,   855/855
(100 %)
4 diff
(99.6 %id)
FN048863 breast carcinoma .e 1170 to 1280 1 to 111       111/111
(100 %)
0 diff
(100 %id)
DA204446 brain .e 1275 to 1871 2 to 598   tiling clone, capped   597/597
(100 %)
2 diff
(99.7 %id)
DA397811 thalamus .e 1339 to 1826 2 to 489   capped   488/488
(100 %)
6 diff
(98.8 %id)
DB304135 brain .e 2571 to 3070 502 to 1   tiling clone,   502/502
(100 %)
2 diff
(99.7 %id)
DA401341 thalamus .f 1 to 582 2 to 584   tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
TI_154139452   .f 652 to 1293 80 to 716   tiling clone,   637/637
(100 %)
17 diff
(97.4 %id)
BI522192 pooled pancreas and spleen .f 1193 to 1929 807 to 27       781/948
(82 %)
0 diff
(100 %id)
BX393261   .f 1218 to 2008 806 to 1       806/920
(87 %)
28 diff
(97.0 %id)
TI_149298522   .f 1225 to 2002 852 to 86   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 767/784
(97 %)
23 diff
(97.1 %id)
TI_154124666   .f 1226 to 2011 841 to 79   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 763/964
(79 %)
26 diff
(97.4 %id)
TI_154126562   .f 1234 to 2008 856 to 86   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 771/976
(78 %)
8 diff
(99.2 %id)
CA312763 Human Lung Epithelial cells, lung .f 1242 to 2011 788 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 770/774
(99 %)
1 diff
(99.9 %id)
BX114494 liver and spleen .f 1243 to 1894 1 to 652       652/652
(100 %)
3 diff
(99.6 %id)
H47578 liver and spleen .f 1244 to 1657 1 to 424   fully sequenced,   424/424
(100 %)
14 diff
(96.7 %id)
H79912 liver and spleen .f 1244 to 1627 1 to 392       392/442
(88 %)
13 diff
(97.1 %id)
BQ921951 leiomyosarcoma, uterus .f 1257 to 2008 1 to 752       752/767
(98 %)
7 diff
(99.1 %id)
TI_149291281   .f 1282 to 2008 801 to 78   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 724/897
(80 %)
6 diff
(99.4 %id)
BM973921 lung .f 1282 to 2008 742 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 724/736
(98 %)
6 diff
(99.2 %id)
CA418549 Chondrosarcoma Grade II, Left Pelvis .f 1291 to 2011 739 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 721/721
(100 %)
1 diff
(99.9 %id)
AW372565 breast .f 1302 to 1932 7 to 634       628/660
(95 %)
17 diff
(97.5 %id)
BM975545 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 1305 to 2002 716 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 698/698
(100 %)
0 diff
(100 %id)
CA312755 Human Lung Epithelial cells, lung .f 1321 to 2011 709 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
CF130539 Chondrosarcoma Lung Metastasis cell lines, lung .f 1339 to 2002 1 to 663   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
TI_154192531   .f 1339 to 2006 51 to 717   AAA   667/962
(69 %)
1 diff
(99.9 %id)
BU608599 Human Lung Epithelial cells, lung .f 1353 to 2008 674 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 656/656
(100 %)
0 diff
(100 %id)
CA416663 Chondrosarcoma Cell line .f 1356 to 2008 671 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 653/653
(100 %)
2 diff
(99.7 %id)
CN297768 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1368 to 2008 1 to 641   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
AA448911   .f 1368 to 1710 1 to 341   fully sequenced,   341/341
(100 %)
5 diff
(98.6 %id)
CA308380 Alveolar Macrophage, lung .f 1368 to 2009 657 to 16   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 642/642
(100 %)
1 diff
(99.9 %id)
CA424522 cell lines, Chondrosarcoma .f 1383 to 2008 638 to 13   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 626/626
(100 %)
1 diff
(99.9 %id)
BU629743 cell lines, Chondrosarcoma .f 1384 to 2008 643 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 625/625
(100 %)
0 diff
(100 %id)
CA415809 Chondrosarcoma Cell line .f 1388 to 2011 640 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 622/625
(99 %)
2 diff
(99.7 %id)
BX456901 thymus .f 1409 to 2351 1 to 937   AAA   937/952
(98 %)
16 diff
(98.4 %id)
AW162670 brain, frontal lobe .f 1446 to 2006 565 to 5       561/565
(99 %)
0 diff
(100 %id)
CB850708 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 1462 to 2002 559 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 541/541
(100 %)
0 diff
(100 %id)
BE855389 brain, glioblastoma (pooled) .f 1468 to 2002 535 to 1       535/535
(100 %)
0 diff
(100 %id)
DB312172 thalamus .f 1473 to 2011 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
BM843287 stomach .f 1484 to 2002 1 to 519   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 519/519
(100 %)
1 diff
(99.9 %id)
AV758553 bone marrow .f 1493 to 2008 16 to 514   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 499/515
(96 %)
6 diff
(98.9 %id)
AA579643 colon, colon tumor RER+ .f 1514 to 2008 493 to 1       493/493
(100 %)
2 diff
(99.6 %id)
BE878295 large cell carcinoma, undifferentiated, lung .f 1519 to 2003 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
BG108863 retina, Retinal Pigment Epithelium sheets .f 1522 to 1853 1 to 334       334/334
(100 %)
10 diff
(97.1 %id)
BM542236 melanotic melanoma, skin .f 1535 to 2009 1 to 475       475/525
(90 %)
2 diff
(99.7 %id)
N67301 cochlea, ear .f 1540 to 2008 482 to 14   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 469/469
(100 %)
3 diff
(99.4 %id)
AI204133   .f 1540 to 2009 476 to 9       468/476
(98 %)
0 diff
(100 %id)
BE677476 dorsal root ganglia .f 1548 to 2008 463 to 3       461/463
(99 %)
0 diff
(100 %id)
AI291755 carcinoid, lung .f 1558 to 2001 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI805963 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1558 to 2008 469 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 451/451
(100 %)
0 diff
(100 %id)
AV758660 bone marrow .f 1563 to 2008 6 to 436   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 431/437
(98 %)
7 diff
(98.4 %id)
AW887429 ovary .f 1581 to 1940 1 to 360       360/360
(100 %)
4 diff
(98.9 %id)
AW887428 ovary .f 1585 to 1869 1 to 285       285/316
(90 %)
17 diff
(94.7 %id)
AI244125 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1587 to 2003 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AW887433 ovary .f 1591 to 1869 1 to 278       278/309
(89 %)
19 diff
(93.9 %id)
AI823804 2 pooled tumors (clear cell type), Kidney .f 1591 to 2009 419 to 1       419/419
(100 %)
3 diff
(99.3 %id)
W44553 senescent fibroblast .f 1598 to 1997 14 to 413       400/414
(96 %)
1 diff
(99.8 %id)
AA302367 aorta .f 1601 to 1921 1 to 321       321/321
(100 %)
1 diff
(99.7 %id)
AW951998   .f 1602 to 2002 1 to 401   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 401/401
(100 %)
1 diff
(99.8 %id)
BU608447 Human Lung Epithelial cells, lung .f 1605 to 2011 425 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 407/410
(99 %)
4 diff
(99.1 %id)
AI660192 thymus, pooled .f 1610 to 2002 423 to 31   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 393/393
(100 %)
6 diff
(98.5 %id)
AI362868 anaplastic oligodendroglioma, brain .f 1622 to 2008 387 to 1       387/387
(100 %)
0 diff
(100 %id)
H47579 liver and spleen .f 1627 to 1987 375 to 1   fully sequenced,   375/375
(100 %)
14 diff
(96.3 %id)
R40161 whole brain .f 1629 to 2002 395 to 11   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 385/387
(99 %)
32 diff
(91.8 %id)
AI061114   .f 1629 to 2008 383 to 4       380/383
(99 %)
0 diff
(100 %id)
TI_57150392   .f 1632 to 2002 76 to 446   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 371/446
(83 %)
6 diff
(98.7 %id)
BI762933 pooled colon, kidney, stomach .f 1633 to 2002 1 to 370   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 370/370
(100 %)
0 diff
(100 %id)
H79818 liver and spleen .f 1635 to 2011 389 to 2       388/440
(88 %)
0 diff
(100 %id)
AI269404 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1647 to 2002 356 to 1       356/356
(100 %)
0 diff
(100 %id)
CN297769 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1656 to 2002 1 to 347   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 347/347
(100 %)
1 diff
(99.8 %id)
AI564703 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1665 to 2008 360 to 17       344/360
(95 %)
0 diff
(100 %id)
R79971 placenta .f 1673 to 2002 334 to 1       334/335
(99 %)
8 diff
(97.7 %id)
AA476588   .f 1680 to 2024 346 to 2   fully sequenced,   345/346
(99 %)
10 diff
(97.2 %id)
AW193042 adenocarcinoma, Pancreas .f 1694 to 2003 310 to 1       310/310
(100 %)
0 diff
(100 %id)
R49271 whole brain .f 1705 to 2009 333 to 24   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 310/335
(92 %)
8 diff
(97.7 %id)
BE887540 leiomyosarcoma, uterus .f 1731 to 2009 1 to 279       279/285
(97 %)
3 diff
(99.0 %id)
AA625697   .f 1733 to 2010 297 to 20   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 278/278
(100 %)
2 diff
(99.3 %id)
T16456   .f 1738 to 2011 274 to 1       274/274
(100 %)
1 diff
(99.7 %id)
AI204401   .f 1740 to 2008 272 to 4       269/272
(98 %)
0 diff
(100 %id)
BX370495   .f 1760 to 2009 1 to 246   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 246/246
(100 %)
4 diff
(98.4 %id)
BU587699 mixed (pool of 40 RNAs) .f 1760 to 2003 1 to 244   AAA   244/250
(97 %)
2 diff
(99.2 %id)
T30351 colon, endothelial .f 1773 to 2002 1 to 230       230/230
(100 %)
0 diff
(100 %id)
BG761391 melanotic melanoma, high MDR (cell line), skin .f 1780 to 2403 1 to 625   tiling clone,   625/800
(78 %)
14 diff
(98.3 %id)
CK906125 Islets of Langerhans, Pancreas .f 1795 to 2380 586 to 1   tiling clone,   586/586
(100 %)
0 diff
(100 %id)
BM127217 Islets of Langerhans, Pancreas .f 1812 to 2380 569 to 1       569/569
(100 %)
0 diff
(100 %id)
AA527070 breast .f 1833 to 2007 175 to 1       175/175
(100 %)
0 diff
(100 %id)
CA975913 sciatic nerve .f 1863 to 2008 1 to 146   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 146/146
(100 %)
0 diff
(100 %id)
AI862538 2 pooled tumors (clear cell type), Kidney .f 1890 to 2016 147 to 21   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 127/127
(100 %)
0 diff
(100 %id)
AW238379 carcinoma in situ from retromolar trigone .f 2037 to 2370 365 to 32   AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 334/336
(99 %)
2 diff
(99.5 %id)
BF103632 embryonal carcinoma, testis .g 1 to 714 2 to 715 E152D K153Q W154M E155G L156T ... tiling clone,   715/719
(99 %)
9 diff
(98.8 %id)
Z41875 brain, total brain .h 1 to 280 1 to 280   tiling clone,   280/280
(100 %)
0 diff
(100 %id)
BI830586 brain, medulla .h 75 to 1025 1 to 971   tiling clone,   971/971
(100 %)
43 diff
(95.6 %id)
TI_57171132   .h 75 to 1025 29 to 999       971/999
(97 %)
48 diff
(95.2 %id)
Z38175 brain, total brain .h 1563 to 1756 194 to 1   tiling clone,   194/194
(100 %)
0 diff
(100 %id)
BI559962 testis .i 1 to 793 1 to 795 exact tiling clone,   795/796
(99 %)
14 diff
(98.3 %id)
TI_44348614   .i 6 to 793 121 to 910 exact     790/911
(86 %)
17 diff
(98.2 %id)
CD704561 normal nasopharynx .i 20 to 624 22 to 627       606/627
(96 %)
7 diff
(98.9 %id)
CX757662 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 42 to 745 9 to 709 E112D N114Y S131C D138G A139C ... tiling clone, Submitted on the opposite strand 701/716
(97 %)
40 diff
(94.5 %id)
BF106396 lung .j 1 to 525 1 to 523 F71L V72S N73T C78V E79K ... tiling clone,   523/524
(99 %)
5 diff
(99.1 %id)
CA942501 Pancreas, Purified pancreatic islet .k-u 1 to 584 583 to 1   tiling clone, Submitted on the opposite strand 583/583
(100 %)
4 diff
(99.4 %id)
AK055282 brain .k-u 327 to 3218 1 to 2892 exact tiling clone, available from FLJ,   2892/2892
(100 %)
7 diff
(99.8 %id)
DA484890 brain .k-u 328 to 900 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
AA766452 germinal center B cell .k-u 509 to 908 23 to 421   tiling clone, Submitted on the opposite strand 399/421
(94 %)
6 diff
(98.6 %id)
AA070843   .k-u 836 to 1104 1 to 275   tiling clone, fully sequenced, Submitted on the opposite strand 275/275
(100 %)
0 diff
(100 %id)
F02196 brain, total brain .k-u 839 to 1170 1 to 332       332/332
(100 %)
17 diff
(94.9 %id)
BX108493 germinal center B cell .k-u 928 to 1435 508 to 1   tiling clone, Submitted on the opposite strand 508/508
(100 %)
0 diff
(100 %id)
BF808631 colon_ins .k-u 960 to 1363 8 to 411       404/411
(98 %)
6 diff
(98.6 %id)
AA336363 endometrium .k-u 974 to 1296 1 to 323       323/323
(100 %)
0 diff
(100 %id)
AW966182   .k-u 975 to 1561 1 to 584       584/632
(92 %)
17 diff
(97.4 %id)
AA070074   .k-u 1074 to 1404 330 to 1   fully sequenced, Submitted on the opposite strand 330/330
(100 %)
1 diff
(99.7 %id)
AW804035 uterus .k-u 1707 to 2172 1 to 466       466/466
(100 %)
9 diff
(98.1 %id)
DB525214.
matches multiple genes
testis .k-u 1779 to 2221 443 to 1     also hits gene KDM2B 443/443
(100 %)
0 diff
(100 %id)
BP385901 pancreatic islet .k-u 1785 to 2123 341 to 1       341/341
(100 %)
3 diff
(99.2 %id)
DB550946.
matches multiple genes
hippocampus .k-u 1789 to 2299 511 to 1     also hits gene KDM2B 511/511
(100 %)
0 diff
(100 %id)
FN116411 breast carcinoma .k-u 1862 to 1967 1 to 105       105/106
(99 %)
2 diff
(98.2 %id)
TI_154108406   .k-u 1875 to 2820 951 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 936/1032
(90 %)
0 diff
(100 %id)
TI_154034911   .k-u 1913 to 2828 957 to 52   tiling clone,   906/1050
(86 %)
0 diff
(100 %id)
AA361882   .k-u 2015 to 2304 1 to 290       290/290
(100 %)
0 diff
(100 %id)
AW963191   .k-u 2016 to 2562 1 to 545       545/545
(100 %)
21 diff
(96.2 %id)
BF974553 B-cells, primary B-cells from tonsils (cell line) .k-u 2064 to 2857 1 to 791       791/896
(88 %)
22 diff
(97.6 %id)
AA182467   .k-u 2080 to 2482 1 to 406       406/407
(99 %)
12 diff
(97.1 %id)
AW771282 Kidney .k-u 2093 to 2454 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
BE386720 melanotic melanoma, skin .k-u 2196 to 2831 1 to 635       635/758
(83 %)
7 diff
(99.1 %id)
BF829157 head_normal .k-u 2285 to 2618 22 to 356       335/367
(91 %)
11 diff
(97.1 %id)
BU623219 cell lines, Chondrosarcoma .k-u 2460 to 3218 776 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 758/760
(99 %)
1 diff
(99.9 %id)
CN344773 embryonic stem cells, DMSO-treated H9 cellline .k-u 2474 to 3027 6 to 559       554/560
(98 %)
6 diff
(99.0 %id)
FN094461 breast carcinoma .k-u 2554 to 2659 1 to 105       105/108
(97 %)
2 diff
(98.2 %id)
BC059954 Bone, osteosarcoma .k-u 2567 to 3218 1 to 652 exact available from MGC, AAA Possibly primed on the genome, locally A rich (30/32 A in genome downstream of last aligned base) 652/652
(100 %)
1 diff
(99.9 %id)
BG111964 Bone, osteosarcoma, cell line .k-u 2568 to 3206 1 to 640 S73V Q74P S75E P76S P77R ... available from MGC, AAA   640/657
(97 %)
8 diff
(98.8 %id)
DB315136 brain .k-u 2679 to 3218 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
DB258443 uterus .l 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
AK096994 small intestine .m 1 to 1602 2 to 1603 exact tiling clone, available from FLJ,   1603/1603
(100 %)
0 diff
(100 %id)
DA923305 small intestine .m 1 to 560 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BQ312016 breast_normal .m 275 to 499 246 to 24       223/249
(89 %)
0 diff
(100 %id)
AK130355 Prostate .n-u 1 to 1776 1 to 1774   tiling clone, available from FLJ,   1774/1774
(100 %)
2 diff
(99.9 %id)
BF513630   .n-u 111 to 615 14 to 518   tiling clone, Submitted on the opposite strand 505/518
(97 %)
2 diff
(99.7 %id)
AA376946 small intestine .n-u 600 to 897 1 to 299       299/299
(100 %)
2 diff
(99.4 %id)
CN265309 embryonic stem cells, cell lines H1, H7, andH9 .n-u 660 to 1307 1 to 644   tiling clone,   644/644
(100 %)
4 diff
(99.4 %id)
BG681273 skin, squamous cell carcinoma .n-u 1316 to 2011 1 to 694 L15* tiling clone,   694/694
(100 %)
2 diff
(99.8 %id)
DB507215 testis .n-u 1645 to 2054 1 to 407   AAA Submitted on the opposite strand 407/407
(100 %)
10 diff
(97.6 %id)
AI439554 B-cell, chronic lymphotic leukemia .n-u 1953 to 2136 184 to 1       184/184
(100 %)
0 diff
(100 %id)
AW975663   .n-u 2011 to 2353 111 to 453   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 343/453
(75 %)
6 diff
(98.7 %id)
AA730474 Ewing's sarcoma .n-u 2029 to 2354 1 to 325   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 325/326
(99 %)
3 diff
(99.1 %id)
AI024622   .n-u 2151 to 2369 219 to 1   tiling clone,   219/219
(100 %)
2 diff
(99.1 %id)
DA644016   .o 1 to 541 2 to 543 G23W A24S V25C R26Q Q28P ... tiling clone, capped   542/542
(100 %)
1 diff
(99.9 %id)
BX507291 Liver .p-u 1 to 601 1 to 602   tiling clone,   602/602
(100 %)
3 diff
(99.6 %id)
CN297770 embryonic stem cells, DMSO-treated H9 cellline .p-u 63 to 592 1 to 530       530/530
(100 %)
0 diff
(100 %id)
AK024957 colon .p-u 271 to 2244 1 to 1974 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 1974/1974
(100 %)
0 diff
(100 %id)
BF843676 head_neck .p-u 326 to 598 1 to 270       270/288
(93 %)
10 diff
(96.6 %id)
DA837821 placenta .p-u 482 to 1024 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
BI012556 lung_normal .p-u 623 to 748 1 to 126       126/137
(91 %)
7 diff
(94.9 %id)
CD359630 testis .p-u 673 to 1490 1 to 830 V48G S58K E59*     830/902
(92 %)
25 diff
(97.3 %id)
AA225911   .p-u 1040 to 1459 1 to 424       424/424
(100 %)
6 diff
(98.6 %id)
CB109040 Liver .p-u 1090 to 1486 1 to 397 exact     397/397
(100 %)
3 diff
(99.3 %id)
CB105693 Liver .q-u 1 to 301 1 to 301   tiling clone,   301/301
(100 %)
1 diff
(99.7 %id)
BM805768 brain, hippocampus .q-u 18 to 498 1 to 484 exact     484/1150
(42 %)
14 diff
(98.8 %id)
TI_57198488   .q-u 26 to 776 52 to 802 A41Q G42A C43A R44G T45P ...     751/807
(93 %)
12 diff
(98.6 %id)
BC046174 Duodenum, adenocarcinoma .q-u 30 to 1226 1 to 1197 exact available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1197/1197
(100 %)
5 diff
(99.6 %id)
BG024182 duodenal adenocarcinoma, cell line, small intestine .q-u 30 to 327 1 to 298   available from MGC,   298/298
(100 %)
0 diff
(100 %id)
BC039029 Brain, Lung, Testis, adult, pooled whole .q-u 30 to 1226 1 to 1197 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1197/1198
(99 %)
4 diff
(99.7 %id)
BI821017 pooled brain, lung, testis .q-u 30 to 776 1 to 747 A41Q G42A C43A R44G T45P ... available from MGC,   747/752
(99 %)
10 diff
(98.7 %id)
TI_57151018   .q-u 148 to 1030 56 to 939       884/943
(93 %)
25 diff
(97.4 %id)
BC029038 Colon, Kidney, Stomach, adult, whole pooled .q-u 155 to 1226 1 to 1072   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1072/1072
(100 %)
3 diff
(99.8 %id)
BI762417 pooled colon, kidney, stomach .q-u 155 to 1030 1 to 877   available from MGC,   877/881
(99 %)
21 diff
(97.7 %id)
BI043511 ovary .q-u 446 to 900 20 to 472       453/472
(95 %)
6 diff
(98.8 %id)
BQ652355 hepatocellular carcinoma, cell line, Liver .q-u 460 to 1253 1 to 796   tiling clone,   796/1017
(78 %)
16 diff
(98.5 %id)
BQ648103 hepatocellular carcinoma, cell line, Liver .q-u 467 to 963 1 to 496       496/1052
(47 %)
15 diff
(98.6 %id)
BQ649529 hepatocellular carcinoma, cell line, Liver .q-u 474 to 1226 1 to 752   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 752/752
(100 %)
4 diff
(99.5 %id)
BQ652387 hepatocellular carcinoma, cell line, Liver .q-u 488 to 1245 1 to 761       761/930
(81 %)
18 diff
(98.1 %id)
BF351243 head_neck .q-u 569 to 947 387 to 11       377/387
(97 %)
0 diff
(100 %id)
CN315364 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .q-u 767 to 1393 12 to 649       638/649
(98 %)
6 diff
(99.1 %id)
AW572402 colon, moderately-differentiated adenocarcinoma .q-u 778 to 1226 449 to 1       449/449
(100 %)
0 diff
(100 %id)
BQ300926 bladder_tumor .q-u 783 to 1122 1 to 333       333/333
(100 %)
10 diff
(97.0 %id)
AW470494 colon, moderately-differentiated adenocarcinoma .q-u 922 to 1226 305 to 1       305/305
(100 %)
0 diff
(100 %id)
BF831702 head_neck .q-u 1048 to 1407 8 to 366       359/366
(98 %)
6 diff
(98.4 %id)
BF831574 head_neck .q-u 1055 to 1226 12 to 181   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 170/181
(93 %)
6 diff
(96.7 %id)
BF831739 head_neck .q-u 1055 to 1403 9 to 354       346/354
(97 %)
8 diff
(97.8 %id)
BQ358712 head_neck .q-u 1055 to 1409 23 to 374       352/374
(94 %)
6 diff
(98.4 %id)
BF799640 colon_ins .q-u 1062 to 1564 512 to 4     Submitted on the opposite strand 509/512
(99 %)
0 diff
(100 %id)
BF831573 head_neck .q-u 1063 to 1258 1 to 197   tiling clone,   197/198
(99 %)
6 diff
(97.0 %id)
BQ376551 testis_normal .q-u 1067 to 1226 1 to 161   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 161/161
(100 %)
10 diff
(93.8 %id)
BF831737 head_neck .q-u 1072 to 1213 1 to 140       140/140
(100 %)
6 diff
(95.8 %id)
BF831570 head_neck .q-u 1077 to 1296 1 to 223       223/252
(88 %)
24 diff
(90.5 %id)
BF831741 head_neck .q-u 1079 to 1270 1 to 191       191/191
(100 %)
5 diff
(97.4 %id)
BF831740 head_neck .q-u 1084 to 1388 1 to 304       304/304
(100 %)
9 diff
(97.1 %id)
BF831558 head_neck .q-u 1085 to 1241 7 to 164       158/164
(96 %)
6 diff
(96.4 %id)
BF831736 head_neck .q-u 1086 to 1305 12 to 233       222/233
(95 %)
6 diff
(97.5 %id)
BF755144 colon .q-u 1104 to 1255 1 to 151       151/183
(82 %)
7 diff
(96.2 %id)
AW887732 ovary .q-u 1105 to 1252 1 to 151       151/173
(87 %)
8 diff
(95.4 %id)
BF831703 head_neck .q-u 1155 to 1552 403 to 10     Submitted on the opposite strand 394/405
(97 %)
0 diff
(100 %id)
BQ358703 head_neck .q-u 1168 to 1525 360 to 3       358/362
(98 %)
0 diff
(100 %id)
BF831729 head_neck .q-u 1191 to 1550 375 to 16     Submitted on the opposite strand 360/375
(96 %)
0 diff
(100 %id)
BF831725 head_neck .q-u 1193 to 1552 372 to 11     Submitted on the opposite strand 362/372
(97 %)
0 diff
(100 %id)
BF831728 head_neck .q-u 1214 to 1516 312 to 14     Submitted on the opposite strand 299/312
(95 %)
0 diff
(100 %id)
BF831527 head_neck .q-u 1227 to 1502 278 to 2     Submitted on the opposite strand 277/343
(80 %)
0 diff
(100 %id)
BG953530 colon .q-u 1227 to 1553 338 to 14       325/381
(85 %)
0 diff
(100 %id)
BF831545 head_neck .q-u 1233 to 1512 284 to 1     Submitted on the opposite strand 284/285
(99 %)
10 diff
(96.5 %id)
BF831465 head_neck .q-u 1235 to 1398 170 to 7     Submitted on the opposite strand 164/170
(96 %)
0 diff
(100 %id)
BF831529 head_neck .q-u 1236 to 1515 279 to 1     Submitted on the opposite strand 279/279
(100 %)
15 diff
(94.7 %id)
BF831553 head_neck .q-u 1238 to 1525 293 to 6   tiling clone, Submitted on the opposite strand 288/293
(98 %)
3 diff
(99.0 %id)
BF831696 head_neck .q-u 1242 to 1553 1 to 313   tiling clone,   313/313
(100 %)
20 diff
(93.7 %id)
BF831694 head_neck .q-u 1244 to 1550 308 to 2     Submitted on the opposite strand 307/308
(99 %)
0 diff
(100 %id)
BQ358713 head_neck .q-u 1250 to 1516 268 to 3       266/276
(96 %)
0 diff
(100 %id)
BF831532 head_neck .q-u 1272 to 1535 266 to 1     Submitted on the opposite strand 266/266
(100 %)
15 diff
(94.4 %id)
BI039923 nervous_tumor .q-u 1278 to 1480 223 to 17       207/223
(92 %)
0 diff
(100 %id)
BF831552 head_neck .q-u 1322 to 1513 195 to 3     Submitted on the opposite strand 193/195
(98 %)
0 diff
(100 %id)
BF831698 head_neck .q-u 1335 to 1535 198 to 1     Submitted on the opposite strand 198/223
(88 %)
9 diff
(96.0 %id)
BF831566 head_neck .q-u 1341 to 1553 42 to 255   tiling clone,   214/259
(82 %)
5 diff
(98.1 %id)
BF831524 head_neck .q-u 1364 to 1553 4 to 194       191/198
(96 %)
6 diff
(97.0 %id)
BF831548 head_neck .q-u 1373 to 1553 1 to 182       182/185
(98 %)
8 diff
(95.7 %id)
BF831534 head_neck .q-u 1383 to 1553 1 to 171       171/175
(97 %)
10 diff
(94.3 %id)
BF799641 colon_ins .q-u 1444 to 1510 65 to 2     Submitted on the opposite strand 436/476
(91 %)
6 diff
(98.8 %id)
AI865194 lymph node, lymphoma, follicular mixed small and largecell .r-u 1 to 384 387 to 2   tiling clone,   386/387
(99 %)
0 diff
(100 %id)
AW444987   .r-u 321 to 868 565 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 548/562
(97 %)
1 diff
(99.9 %id)
AA174197   .r-u 671 to 877 206 to 2   tiling clone,   205/206
(99 %)
0 diff
(100 %id)
BP318771 pericardium .s 1 to 592 2 to 593 exact tiling clone,   593/593
(100 %)
1 diff
(99.9 %id)
DB093824 testis .t-u 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
DB067569 testis .u 1 to 458 2 to 459 exact tiling clone, capped   458/458
(100 %)
0 diff
(100 %id)
DB442380 testis .va 1 to 433 1 to 434 S23L A24S F25I A26C G27R ... tiling clone,   434/437
(99 %)
3 diff
(99.4 %id)
AW888849 nervous_tumor Gene RNF34, variant not shown         Suspected internal deletion, this clone was ignored    
AW888857 nervous_tumor Gene RNF34, variant not shown              
BF177295 blood Gene RNF34, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DA103664 cerebellum Gene RNF34, variant not shown       capped      
DC323675 brain Gene RNF34, variant not shown              
CD687824 normal nasopharynx Gene RNF34, variant not shown         Suspected internal deletion, this clone was ignored    
AL041998 testis Gene RNF34, variant not shown              
AL042001 testis Gene RNF34, variant not shown              
BX956906   Gene RNF34, variant not shown         Suspected internal deletion, this clone was ignored    
DB506581 hypothalamus Gene RNF34, variant not shown         Submitted on the opposite strand    
DB577861 hypothalamus Gene RNF34, variant not shown         Submitted on the opposite strand    
W04944 liver and spleen Gene RNF34, variant not shown              
DB321010 Kidney Gene RNF34, variant not shown         This clone was ignored    
DA635947 Kidney Gene RNF34, variant not shown       capped This clone was ignored    
DB361688 mammary gland Gene RNF34, variant not shown         Suspected internal deletion, this clone was ignored    
DA646908 mammary gland Gene RNF34, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB246618   Gene RNF34, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB350707   Gene RNF34, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n-u, .o, .p-u, .q-u, .r-u, .s, .t-u, .u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI